nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofedanol—HRH1—Amine ligand-binding receptors—TAAR6—schizophrenia	0.0254	0.0342	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR6—schizophrenia	0.0253	0.034	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—CHRM1—schizophrenia	0.0223	0.03	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR6—schizophrenia	0.0212	0.0285	CbGpPWpGaD
Clofedanol—HRH1—IL-4 Signaling Pathway—FES—schizophrenia	0.0204	0.0274	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—CHRM1—schizophrenia	0.0188	0.0252	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR1B—schizophrenia	0.0159	0.0214	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR1A—schizophrenia	0.0153	0.0206	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR2C—schizophrenia	0.0148	0.0199	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—DRD1—schizophrenia	0.0148	0.0199	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—DRD3—schizophrenia	0.0143	0.0192	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—DRD4—schizophrenia	0.0139	0.0187	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR1B—schizophrenia	0.0134	0.018	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—DRD2—schizophrenia	0.0129	0.0174	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR7—schizophrenia	0.0129	0.0174	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR1A—schizophrenia	0.0129	0.0173	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—DRD1—schizophrenia	0.0124	0.0167	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR2C—schizophrenia	0.0124	0.0167	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—DRD3—schizophrenia	0.012	0.0162	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—DRD4—schizophrenia	0.0117	0.0157	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—DRD2—schizophrenia	0.0109	0.0146	CbGpPWpGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR7—schizophrenia	0.0109	0.0146	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—DGKI—schizophrenia	0.00945	0.0127	CbGpPWpGaD
Clofedanol—HRH1—Monoamine GPCRs—HTR2A—schizophrenia	0.00907	0.0122	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKI—schizophrenia	0.00845	0.0114	CbGpPWpGaD
Clofedanol—Orphenadrine—GRIN2D—schizophrenia	0.00793	0.031	CrCbGaD
Clofedanol—HRH1—Amine ligand-binding receptors—HTR2A—schizophrenia	0.00762	0.0102	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—NTS—schizophrenia	0.00683	0.00919	CbGpPWpGaD
Clofedanol—Levomethadyl Acetate—CHRNA3—schizophrenia	0.00646	0.0252	CrCbGaD
Clofedanol—Doxylamine—CHRM1—schizophrenia	0.00617	0.0241	CrCbGaD
Clofedanol—Isopropamide—CHRM1—schizophrenia	0.00617	0.0241	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—schizophrenia	0.00611	0.00822	CbGpPWpGaD
Clofedanol—Alverine—HTR1A—schizophrenia	0.00596	0.0233	CrCbGaD
Clofedanol—Mepenzolate—CHRM1—schizophrenia	0.00583	0.0228	CrCbGaD
Clofedanol—Captodiame—DRD3—schizophrenia	0.00578	0.0226	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—CHRM1—schizophrenia	0.00557	0.00749	CbGpPWpGaD
Clofedanol—Orphenadrine—GRIN1—schizophrenia	0.00536	0.0209	CrCbGaD
Clofedanol—Amitriptyline—NTRK2—schizophrenia	0.00535	0.0209	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—GRM5—schizophrenia	0.00518	0.00696	CbGpPWpGaD
Clofedanol—Diphenidol—CHRM1—schizophrenia	0.00511	0.0199	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.005	0.00673	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM1—schizophrenia	0.00498	0.0067	CbGpPWpGaD
Clofedanol—Benzphetamine—SLC18A2—schizophrenia	0.00495	0.0193	CrCbGaD
Clofedanol—HRH1—IL-4 Signaling Pathway—FOS—schizophrenia	0.00489	0.00658	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.00488	0.00655	CbGpPWpGaD
Clofedanol—Captodiame—HTR2C—schizophrenia	0.00485	0.0189	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—CCK—schizophrenia	0.00474	0.00637	CbGpPWpGaD
Clofedanol—Disopyramide—CHRM1—schizophrenia	0.00467	0.0182	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—schizophrenia	0.00463	0.00623	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—CCKAR—schizophrenia	0.00454	0.00611	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.00453	0.00608	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.00431	0.00579	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—schizophrenia	0.00424	0.0057	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00418	0.00562	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—schizophrenia	0.00406	0.00546	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—FZD3—schizophrenia	0.00405	0.00545	CbGpPWpGaD
Clofedanol—Atomoxetine—HTR6—schizophrenia	0.00398	0.0155	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—OXT—schizophrenia	0.00397	0.00534	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—TAAR6—schizophrenia	0.00381	0.00512	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—GRM2—schizophrenia	0.00381	0.00512	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—NPS—schizophrenia	0.00376	0.00506	CbGpPWpGaD
Clofedanol—HRH1—G alpha (q) signalling events—HTR2C—schizophrenia	0.00369	0.00496	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.00369	0.00496	CbGpPWpGaD
Clofedanol—Clomipramine—HTR6—schizophrenia	0.00356	0.0139	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	0.00355	0.00477	CbGpPWpGaD
Clofedanol—Toremifene—ESR1—schizophrenia	0.00354	0.0138	CrCbGaD
Clofedanol—Chlorprothixene—HTR6—schizophrenia	0.00354	0.0138	CrCbGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.00351	0.00472	CbGpPWpGaD
Clofedanol—Brompheniramine—CHRM1—schizophrenia	0.00347	0.0136	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—NTS—schizophrenia	0.00345	0.00463	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.0034	0.00458	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	0.00337	0.00452	CbGpPWpGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.0033	0.00444	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—GRM3—schizophrenia	0.00324	0.00436	CbGpPWpGaD
Clofedanol—HRH1—IL-4 Signaling Pathway—EP300—schizophrenia	0.00324	0.00436	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR6—schizophrenia	0.00318	0.00428	CbGpPWpGaD
Clofedanol—Trimipramine—HTR3A—schizophrenia	0.00316	0.0123	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00314	0.00422	CbGpPWpGaD
Clofedanol—Doxepin—HTR6—schizophrenia	0.00312	0.0122	CrCbGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.00307	0.00413	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00301	0.00404	CbGpPWpGaD
Clofedanol—Methadone—HTR3A—schizophrenia	0.003	0.0117	CrCbGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.00295	0.00397	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00292	0.00392	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.00285	0.00383	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.00285	0.00383	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CHRM1—schizophrenia	0.00281	0.00378	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.00276	0.00371	CbGpPWpGaD
Clofedanol—Toremifene—CYP1A2—schizophrenia	0.00273	0.0107	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00272	0.00366	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—DGKI—schizophrenia	0.00269	0.00362	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00268	0.00361	CbGpPWpGaD
Clofedanol—Clemastine—CYP2D6—schizophrenia	0.00266	0.0104	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00263	0.00353	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00263	0.00353	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—GRM5—schizophrenia	0.00261	0.00351	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.00256	0.00344	CbGpPWpGaD
Clofedanol—Chlorprothixene—CHRM1—schizophrenia	0.00255	0.00995	CrCbGaD
Clofedanol—Clomipramine—GSTP1—schizophrenia	0.00254	0.00992	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00253	0.0034	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.0025	0.00336	CbGpPWpGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.0025	0.00336	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00249	0.00335	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—DGKI—schizophrenia	0.00245	0.00329	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00244	0.00329	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00244	0.00329	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR6—schizophrenia	0.00244	0.00952	CrCbGaD
Clofedanol—Imipramine—HTR6—schizophrenia	0.00243	0.00947	CrCbGaD
Clofedanol—Chlorphenamine—SLC6A3—schizophrenia	0.00242	0.00946	CrCbGaD
Clofedanol—Amitriptyline—HTR6—schizophrenia	0.00241	0.00941	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—CCK—schizophrenia	0.00239	0.00321	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00237	0.00318	CbGpPWpGaD
Clofedanol—Cyclobenzaprine—CYP1A2—schizophrenia	0.00236	0.00921	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.0023	0.00309	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—CCKAR—schizophrenia	0.00229	0.00308	CbGpPWpGaD
Clofedanol—Promethazine—CHRM1—schizophrenia	0.00227	0.00886	CrCbGaD
Clofedanol—HRH1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00226	0.00304	CbGpPWpGaD
Clofedanol—Atomoxetine—HTR1B—schizophrenia	0.00225	0.0088	CrCbGaD
Clofedanol—Doxepin—CHRM1—schizophrenia	0.00225	0.00877	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00224	0.00301	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—ADORA2A—schizophrenia	0.00222	0.00299	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00219	0.00295	CbGpPWpGaD
Clofedanol—Tripelennamine—CYP2D6—schizophrenia	0.00219	0.00856	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—TAAR6—schizophrenia	0.00215	0.0029	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM2—schizophrenia	0.00215	0.0029	CbGpPWpGaD
Clofedanol—Aprindine—CYP2D6—schizophrenia	0.00214	0.00836	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.00214	0.00288	CbGpPWpGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.00214	0.00288	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—FZD3—schizophrenia	0.00208	0.0028	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—NPY—schizophrenia	0.00208	0.00279	CbGpPWpGaD
Clofedanol—Benzphetamine—SLC6A3—schizophrenia	0.00205	0.00801	CrCbGaD
Clofedanol—Atomoxetine—SLC6A3—schizophrenia	0.00204	0.00795	CrCbGaD
Clofedanol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00202	0.00272	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR1B—schizophrenia	0.002	0.00269	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—OXT—schizophrenia	0.002	0.00269	CbGpPWpGaD
Clofedanol—Promazine—CHRM1—schizophrenia	0.002	0.00779	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—NGEF—schizophrenia	0.00199	0.00268	CbGpPWpGaD
Clofedanol—Cyclobenzaprine—HTR2A—schizophrenia	0.00199	0.00778	CrCbGaD
Clofedanol—HRH1—IL-4 Signaling Pathway—AKT1—schizophrenia	0.00196	0.00263	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GRM2—schizophrenia	0.00196	0.00263	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PPP3CC—schizophrenia	0.00196	0.00263	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—TAAR6—schizophrenia	0.00196	0.00263	CbGpPWpGaD
Clofedanol—Chlorprothixene—DRD3—schizophrenia	0.00195	0.0076	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—NTS—schizophrenia	0.00195	0.00262	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR1A—schizophrenia	0.00193	0.00259	CbGpPWpGaD
Clofedanol—Chlorprothixene—DRD1—schizophrenia	0.00191	0.00746	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—NPS—schizophrenia	0.0019	0.00255	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2C—schizophrenia	0.00186	0.0025	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—DRD1—schizophrenia	0.00186	0.0025	CbGpPWpGaD
Clofedanol—Clotrimazole—CYP1A2—schizophrenia	0.00184	0.0072	CrCbGaD
Clofedanol—Atomoxetine—HTR2C—schizophrenia	0.00184	0.00717	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM3—schizophrenia	0.00183	0.00246	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—RGS4—schizophrenia	0.00183	0.00246	CbGpPWpGaD
Clofedanol—Cyclobenzaprine—CYP2D6—schizophrenia	0.00182	0.00711	CrCbGaD
Clofedanol—Chlorphenamine—SLC6A4—schizophrenia	0.00181	0.00708	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—NGEF—schizophrenia	0.00181	0.00243	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—DRD3—schizophrenia	0.0018	0.00242	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR6—schizophrenia	0.0018	0.00242	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NTS—schizophrenia	0.00177	0.00238	CbGpPWpGaD
Clofedanol—Promazine—DRD4—schizophrenia	0.00177	0.0069	CrCbGaD
Clofedanol—Chlorpromazine—CHRM1—schizophrenia	0.00176	0.00686	CrCbGaD
Clofedanol—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00175	0.00235	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—DRD4—schizophrenia	0.00175	0.00235	CbGpPWpGaD
Clofedanol—Imipramine—CHRM1—schizophrenia	0.00175	0.00682	CrCbGaD
Clofedanol—Amitriptyline—CHRM1—schizophrenia	0.00174	0.00678	CrCbGaD
Clofedanol—Trimipramine—SLC6A3—schizophrenia	0.00168	0.00654	CrCbGaD
Clofedanol—HRH1—GPCR ligand binding—CNR1—schizophrenia	0.00167	0.00225	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—RGS4—schizophrenia	0.00166	0.00224	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—GRM3—schizophrenia	0.00166	0.00224	CbGpPWpGaD
Clofedanol—Clomipramine—HTR2C—schizophrenia	0.00164	0.00641	CrCbGaD
Clofedanol—Chlorprothixene—HTR2C—schizophrenia	0.00164	0.00639	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR6—schizophrenia	0.00163	0.00219	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR7—schizophrenia	0.00163	0.00219	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—DRD2—schizophrenia	0.00163	0.00219	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CHRM1—schizophrenia	0.00159	0.00213	CbGpPWpGaD
Clofedanol—Chlorpromazine—DRD4—schizophrenia	0.00156	0.00608	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—IL3RA—schizophrenia	0.00155	0.00208	CbGpPWpGaD
Clofedanol—Atomoxetine—SLC6A4—schizophrenia	0.00152	0.00595	CrCbGaD
Clofedanol—Trimipramine—HTR2C—schizophrenia	0.00151	0.0059	CrCbGaD
Clofedanol—Toremifene—ABCB1—schizophrenia	0.0015	0.00587	CrCbGaD
Clofedanol—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.0015	0.00202	CbGpPWpGaD
Clofedanol—Carbinoxamine—CYP2D6—schizophrenia	0.0015	0.00585	CrCbGaD
Clofedanol—Promazine—DRD1—schizophrenia	0.0015	0.00584	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—GRM5—schizophrenia	0.00148	0.00198	CbGpPWpGaD
Clofedanol—Trimipramine—HTR1A—schizophrenia	0.00147	0.00573	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—DGKI—schizophrenia	0.00145	0.00194	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CHRM1—schizophrenia	0.00144	0.00194	CbGpPWpGaD
Clofedanol—Doxepin—HTR2C—schizophrenia	0.00144	0.00562	CrCbGaD
Clofedanol—Chlorpromazine—HTR7—schizophrenia	0.00143	0.00557	CrCbGaD
Clofedanol—Clotrimazole—CYP2D6—schizophrenia	0.00142	0.00556	CrCbGaD
Clofedanol—Imipramine—HTR7—schizophrenia	0.00142	0.00554	CrCbGaD
Clofedanol—Tamoxifen—ESR1—schizophrenia	0.00141	0.00552	CrCbGaD
Clofedanol—Amitriptyline—HTR7—schizophrenia	0.00141	0.00551	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—IL3RA—schizophrenia	0.00141	0.00189	CbGpPWpGaD
Clofedanol—Doxepin—HTR1A—schizophrenia	0.0014	0.00546	CrCbGaD
Clofedanol—Amitriptyline—HTR1B—schizophrenia	0.00137	0.00534	CrCbGaD
Clofedanol—Clomipramine—SLC6A4—schizophrenia	0.00136	0.00531	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—CCK—schizophrenia	0.00135	0.00181	CbGpPWpGaD
Clofedanol—Chlorprothixene—DRD2—schizophrenia	0.00135	0.00526	CrCbGaD
Clofedanol—Chlorpromazine—DRD3—schizophrenia	0.00134	0.00524	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—GRM5—schizophrenia	0.00134	0.0018	CbGpPWpGaD
Clofedanol—Amitriptyline—DRD3—schizophrenia	0.00133	0.00518	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—PPP1R1B—schizophrenia	0.00132	0.00178	CbGpPWpGaD
Clofedanol—Chlorpromazine—DRD1—schizophrenia	0.00132	0.00514	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—PDE4B—schizophrenia	0.00132	0.00177	CbGpPWpGaD
Clofedanol—Brompheniramine—CYP2D6—schizophrenia	0.0013	0.00507	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—CCKAR—schizophrenia	0.00129	0.00174	CbGpPWpGaD
Clofedanol—Promazine—HTR2C—schizophrenia	0.00128	0.005	CrCbGaD
Clofedanol—Chlorphenamine—CYP2D6—schizophrenia	0.00127	0.00497	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—ADORA2A—schizophrenia	0.00126	0.00169	CbGpPWpGaD
Clofedanol—Trimipramine—SLC6A4—schizophrenia	0.00125	0.00489	CrCbGaD
Clofedanol—Trimipramine—DRD2—schizophrenia	0.00125	0.00486	CrCbGaD
Clofedanol—Imipramine—SLC6A3—schizophrenia	0.00124	0.00485	CrCbGaD
Clofedanol—Clomipramine—CYP1A2—schizophrenia	0.00124	0.00484	CrCbGaD
Clofedanol—Dextropropoxyphene—CYP2D6—schizophrenia	0.00123	0.0048	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—FZD3—schizophrenia	0.00123	0.00165	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—CCK—schizophrenia	0.00123	0.00165	CbGpPWpGaD
Clofedanol—Promethazine—DRD2—schizophrenia	0.0012	0.00468	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—PDE4B—schizophrenia	0.00119	0.00161	CbGpPWpGaD
Clofedanol—Doxepin—SLC6A4—schizophrenia	0.00119	0.00466	CrCbGaD
Clofedanol—Doxepin—DRD2—schizophrenia	0.00119	0.00463	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—CCKAR—schizophrenia	0.00118	0.00158	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—NPY—schizophrenia	0.00117	0.00158	CbGpPWpGaD
Clofedanol—Loperamide—CYP2D6—schizophrenia	0.00117	0.00458	CrCbGaD
Clofedanol—Atomoxetine—HTR2A—schizophrenia	0.00117	0.00457	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—FES—schizophrenia	0.00116	0.00155	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TAAR6—schizophrenia	0.00116	0.00155	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PPP3CC—schizophrenia	0.00116	0.00155	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GRM2—schizophrenia	0.00116	0.00155	CbGpPWpGaD
Clofedanol—HRH1—GPCR ligand binding—HTR2A—schizophrenia	0.00114	0.00153	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—ADORA2A—schizophrenia	0.00114	0.00153	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR1B—schizophrenia	0.00113	0.00152	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—OXT—schizophrenia	0.00113	0.00152	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR2C—schizophrenia	0.00113	0.0044	CrCbGaD
Clofedanol—Imipramine—HTR2C—schizophrenia	0.00112	0.00438	CrCbGaD
Clofedanol—Diphenhydramine—CYP1A2—schizophrenia	0.00112	0.00437	CrCbGaD
Clofedanol—Amitriptyline—HTR2C—schizophrenia	0.00111	0.00435	CrCbGaD
Clofedanol—Chlorpromazine—HTR1A—schizophrenia	0.00109	0.00427	CrCbGaD
Clofedanol—Tamoxifen—CYP1A2—schizophrenia	0.00109	0.00426	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR1A—schizophrenia	0.00109	0.00146	CbGpPWpGaD
Clofedanol—Imipramine—HTR1A—schizophrenia	0.00109	0.00425	CrCbGaD
Clofedanol—Doxepin—CYP1A2—schizophrenia	0.00109	0.00424	CrCbGaD
Clofedanol—Amitriptyline—HTR1A—schizophrenia	0.00108	0.00422	CrCbGaD
Clofedanol—Methadone—CYP1A2—schizophrenia	0.00108	0.00422	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—NPS—schizophrenia	0.00107	0.00144	CbGpPWpGaD
Clofedanol—Atomoxetine—CYP2D6—schizophrenia	0.00107	0.00418	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—NGEF—schizophrenia	0.00107	0.00144	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPY—schizophrenia	0.00106	0.00143	CbGpPWpGaD
Clofedanol—Promazine—DRD2—schizophrenia	0.00106	0.00412	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2C—schizophrenia	0.00105	0.00141	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—DRD1—schizophrenia	0.00105	0.00141	CbGpPWpGaD
Clofedanol—Clomipramine—HTR2A—schizophrenia	0.00105	0.00408	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—NTS—schizophrenia	0.00104	0.0014	CbGpPWpGaD
Clofedanol—Chlorprothixene—HTR2A—schizophrenia	0.00104	0.00407	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—OXT—schizophrenia	0.00103	0.00138	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—HTR1B—schizophrenia	0.00103	0.00138	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—DRD3—schizophrenia	0.00102	0.00137	CbGpPWpGaD
Clofedanol—Clotrimazole—ABCB1—schizophrenia	0.00102	0.00397	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR1A—schizophrenia	0.000989	0.00133	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—DRD4—schizophrenia	0.000989	0.00133	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—RGS4—schizophrenia	0.000982	0.00132	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GRM3—schizophrenia	0.000982	0.00132	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—RTN4—schizophrenia	0.000982	0.00132	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—NPS—schizophrenia	0.000974	0.00131	CbGpPWpGaD
Clofedanol—Promazine—CYP1A2—schizophrenia	0.000966	0.00377	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—HTR6—schizophrenia	0.000964	0.0013	CbGpPWpGaD
Clofedanol—Trimipramine—HTR2A—schizophrenia	0.000963	0.00376	CrCbGaD
Clofedanol—Clomipramine—CYP2D6—schizophrenia	0.000957	0.00374	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2C—schizophrenia	0.000955	0.00128	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—DRD1—schizophrenia	0.000955	0.00128	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—CNR1—schizophrenia	0.000944	0.00127	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MAG—schizophrenia	0.000931	0.00125	CbGpPWpGaD
Clofedanol—Imipramine—SLC6A4—schizophrenia	0.000929	0.00363	CrCbGaD
Clofedanol—Chlorpromazine—DRD2—schizophrenia	0.000929	0.00363	CrCbGaD
Clofedanol—Promethazine—HTR2A—schizophrenia	0.000927	0.00362	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—DRD3—schizophrenia	0.000925	0.00124	CbGpPWpGaD
Clofedanol—Imipramine—DRD2—schizophrenia	0.000924	0.00361	CrCbGaD
Clofedanol—Amitriptyline—SLC6A4—schizophrenia	0.000923	0.0036	CrCbGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR7—schizophrenia	0.000921	0.00124	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—DRD2—schizophrenia	0.000921	0.00124	CbGpPWpGaD
Clofedanol—Amitriptyline—DRD2—schizophrenia	0.000918	0.00358	CrCbGaD
Clofedanol—Doxepin—HTR2A—schizophrenia	0.000917	0.00358	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—DRD4—schizophrenia	0.000898	0.00121	CbGpPWpGaD
Clofedanol—Trimipramine—CYP2D6—schizophrenia	0.00088	0.00344	CrCbGaD
Clofedanol—Diphenhydramine—CYP2D6—schizophrenia	0.000864	0.00337	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—CNR1—schizophrenia	0.000857	0.00115	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CHRM1—schizophrenia	0.000852	0.00115	CbGpPWpGaD
Clofedanol—Chlorpromazine—CYP1A2—schizophrenia	0.00085	0.00332	CrCbGaD
Clofedanol—Promethazine—CYP2D6—schizophrenia	0.000848	0.00331	CrCbGaD
Clofedanol—Imipramine—CYP1A2—schizophrenia	0.000846	0.0033	CrCbGaD
Clofedanol—Tamoxifen—CYP2D6—schizophrenia	0.000842	0.00329	CrCbGaD
Clofedanol—Amitriptyline—CYP1A2—schizophrenia	0.000841	0.00328	CrCbGaD
Clofedanol—Doxepin—CYP2D6—schizophrenia	0.000839	0.00328	CrCbGaD
Clofedanol—Loperamide—ABCB1—schizophrenia	0.000837	0.00327	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR7—schizophrenia	0.000837	0.00112	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—DRD2—schizophrenia	0.000837	0.00112	CbGpPWpGaD
Clofedanol—Methadone—CYP2D6—schizophrenia	0.000835	0.00326	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—IL3RA—schizophrenia	0.00083	0.00112	CbGpPWpGaD
Clofedanol—Promazine—HTR2A—schizophrenia	0.000815	0.00318	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—TLE1—schizophrenia	0.00081	0.00109	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NRG3—schizophrenia	0.00081	0.00109	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GFAP—schizophrenia	0.000801	0.00108	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GRM5—schizophrenia	0.000792	0.00106	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TLE3—schizophrenia	0.000767	0.00103	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCK—schizophrenia	0.000724	0.000974	CbGpPWpGaD
Clofedanol—Chlorpromazine—HTR2A—schizophrenia	0.000718	0.0028	CrCbGaD
Clofedanol—Imipramine—HTR2A—schizophrenia	0.000714	0.00279	CrCbGaD
Clofedanol—Amitriptyline—HTR2A—schizophrenia	0.000709	0.00277	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—PDE4B—schizophrenia	0.000706	0.000949	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CCKAR—schizophrenia	0.000694	0.000933	CbGpPWpGaD
Clofedanol—Clomipramine—ABCB1—schizophrenia	0.000683	0.00267	CrCbGaD
Clofedanol—Chlorprothixene—ABCB1—schizophrenia	0.00068	0.00266	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—ADORA2A—schizophrenia	0.000673	0.000905	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000662	0.00089	CbGpPWpGaD
Clofedanol—Chlorpromazine—CYP2D6—schizophrenia	0.000656	0.00256	CrCbGaD
Clofedanol—Imipramine—CYP2D6—schizophrenia	0.000653	0.00255	CrCbGaD
Clofedanol—Amitriptyline—CYP2D6—schizophrenia	0.000649	0.00253	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—FGA—schizophrenia	0.000646	0.000868	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—HTR2A—schizophrenia	0.000645	0.000867	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPY—schizophrenia	0.000629	0.000846	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NOTCH4—schizophrenia	0.000629	0.000846	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ATP2A2—schizophrenia	0.000629	0.000846	CbGpPWpGaD
Clofedanol—Trimipramine—ABCB1—schizophrenia	0.000629	0.00245	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—HTR1B—schizophrenia	0.000607	0.000816	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—OXT—schizophrenia	0.000607	0.000816	CbGpPWpGaD
Clofedanol—Promethazine—ABCB1—schizophrenia	0.000605	0.00236	CrCbGaD
Clofedanol—Tamoxifen—ABCB1—schizophrenia	0.000601	0.00235	CrCbGaD
Clofedanol—Doxepin—ABCB1—schizophrenia	0.000599	0.00234	CrCbGaD
Clofedanol—Methadone—ABCB1—schizophrenia	0.000596	0.00233	CrCbGaD
Clofedanol—HRH1—Signaling by GPCR—HTR2A—schizophrenia	0.000586	0.000788	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR1A—schizophrenia	0.000584	0.000785	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NPS—schizophrenia	0.000575	0.000773	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2C—schizophrenia	0.000564	0.000759	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—DRD1—schizophrenia	0.000564	0.000759	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NTRK2—schizophrenia	0.000549	0.000738	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—DRD3—schizophrenia	0.000546	0.000735	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—DRD4—schizophrenia	0.00053	0.000713	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—CNR1—schizophrenia	0.000507	0.000681	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR7—schizophrenia	0.000494	0.000664	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—DRD2—schizophrenia	0.000494	0.000664	CbGpPWpGaD
Clofedanol—Chlorpromazine—ABCB1—schizophrenia	0.000469	0.00183	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—PRL—schizophrenia	0.000467	0.000627	CbGpPWpGaD
Clofedanol—Imipramine—ABCB1—schizophrenia	0.000466	0.00182	CrCbGaD
Clofedanol—Amitriptyline—ABCB1—schizophrenia	0.000463	0.00181	CrCbGaD
Clofedanol—HRH1—Signaling Pathways—S100B—schizophrenia	0.000435	0.000585	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ERBB4—schizophrenia	0.000416	0.000559	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	0.000391	0.000526	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—NRG1—schizophrenia	0.000384	0.000516	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—MEF2C—schizophrenia	0.00038	0.000511	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—YWHAZ—schizophrenia	0.000368	0.000494	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ERBB3—schizophrenia	0.00036	0.000483	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—HTR2A—schizophrenia	0.000346	0.000465	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APOE—schizophrenia	0.000322	0.000433	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—APOA1—schizophrenia	0.000318	0.000428	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—ESR1—schizophrenia	0.000307	0.000413	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—GSK3B—schizophrenia	0.000279	0.000375	CbGpPWpGaD
Clofedanol—HRH1—GPCR downstream signaling—AKT1—schizophrenia	0.000207	0.000278	CbGpPWpGaD
Clofedanol—HRH1—Signaling by GPCR—AKT1—schizophrenia	0.000188	0.000252	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—EP300—schizophrenia	0.000183	0.000247	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—TP53—schizophrenia	0.000131	0.000176	CbGpPWpGaD
Clofedanol—HRH1—Signaling Pathways—AKT1—schizophrenia	0.000111	0.000149	CbGpPWpGaD
